G. Armengol

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial

Françis Couturaud, Jeannot Schmidt, Olivier Sanchez et al. · The Lancet · 2025 · 71 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Role of Toll‐like Receptors 2 and 4 in Mediating Endothelial Dysfunction and Arterial Remodeling in Primary Arterial Antiphospholipid Syndrome

Y. Benhamou, Jérémy Bellien, G. Armengol et al. · Arthritis & Rheumatology · 2014 · 59 citations

Life Sciences, Immunology, Pathology +17

Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study

S. Miranda, Véronique Le Cam‐Duchez, Jacques Bénichou et al. · Thrombosis Research · 2017 · 48 citations

Medicine, Internal Medicine, Pharmacology +12

Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database

C. Faisant, G. Armengol, Laurence Bouillet et al. · Journal of Clinical Immunology · 2015 · 31 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: Role of reduced oxidative stress

Y. Benhamou, S. Miranda, G. Armengol et al. · Vascular Pharmacology · 2015 · 25 citations

Veterinary Medicine, Immunology, Pharmacology +15